| 发明名称 |
Novel Sulfonaminoquinoline Hepcidin Antagonists |
| 摘要 |
The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.
|
| 申请公布号 |
US2012214803(A1) |
申请公布日期 |
2012.08.23 |
| 申请号 |
US201213364566 |
申请日期 |
2012.02.02 |
| 申请人 |
VIFOR (INTERNATIONAL) AG |
发明人 |
BUHR WILM;BURCKHARDT SUSANNA;DUERRENBERGER FRANZ;FUNK FELIX;GEISSER PETER O.;CORDEN VINCENT A.;COURTNEY STEPHEN M.;DAWSON GRAHAM;DAVENPORT TARA;SLACK MARK;RIDGILL MARK P.;YARNOLD CHROSTOPHER J.;BOYCE SUSAN;ELLENBROEK ALBERTUS A. |
| 分类号 |
A61K31/542;A61K31/4706;A61K31/4709;A61K31/497;A61K31/549;A61P3/00;A61P7/06;C07D215/40;C07D215/42;C07D215/46;C07D215/50;C07D401/12;C07D513/04 |
主分类号 |
A61K31/542 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
